Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Immunosuppressants/immunotherapies

Epstein-Barr virus-associated post-transplant lymphoproliferative disorder and sensory polyneuropathy: case report

    • 22 Accesses

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      In R-CHOP regimen, specific corticosteroid component was not mentioned.

    Reference

    1. Mika T, et al. Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes. Frontiers in Medicine 6: Dec 2019. Available from: URL: http://doi.org/10.3389/fmed.2019.00295

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Immunosuppressants/immunotherapies. Reactions Weekly 1791, 139 (2020). https://doi.org/10.1007/s40278-020-74984-0

    Download citation